In December 2018, Level Brands acquired cbdMD, a nationally recognized e-commerce CBD brand with products also available in over 1,000 retail locations nationwide. cbdMD manufactures its premium line of CBD oil products at a North Carolina facility, using all-natural CBD extracted from organic, non-GMO, vegan, and gluten-free industrial hemp grown in the USA.

ADVERTISEMENT

cbdMD offers a comprehensive line of organic, vegan, and THC-free CBD oil products including tinctures, capsules, gummies, topicals, bath bombs, and human-grade pet products. “With Congress passing the 2018 Farm Bill, and as professional sports leagues continue to evaluate the benefits of hemp-derived CBD for their athletes, cbdMD presents a unique alternative to habit-forming medications, such as opioids,” says Caryn Dunayer, Co-founder and President of cbdMD. “We’re looking forward to collaborating with the NFL Players, Inc. to promote the many benefits CBD has on human health. Whether you’re a professional athlete or a casual fan, we want everyone to have the opportunity to maintain a healthy lifestyle through the power of CBD.”

Martin Sumichrast, Chairman and CEO, commented, “Kathy is passionate about the benefits of CBD and is a strong advocate for its use in a variety of settings. We are grateful to her as she helps educate the public on the benefits of CBD. We believe the recent passage of the 2018 Farm Bill, which legalized hemp production and the manufacturing of hemp-derived products at the federal level, will play a key role in driving a rapid increase in acceptance amongst retailers, consumers, and the general public alike.”

According to cannabis industry analysts the Brightfield Group, the hemp-derived CBD market could reach $22 billion by 2022.

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ″should,″ ″may,″ ″intends,″ ″anticipates,″ ″believes,″ ″estimates,″ ″projects,″ ″forecasts,″ ″expects,″ ″plans,″ and ″proposes.″ These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase cbdMD’s market share post-closing, among others. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in Level Brands, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018 as filed with the Securities and Exchange Commission (the “SEC”) on December 12, 2018 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of Level Brands, Inc. and are difficult to predict. Level Brands, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.